Dr. Israa Malli | Microbiology | Best Researcher Award

Dr. Israa Malli | Microbiology | Best Researcher Award

Dr. Israa Malli | Microbiology – Associate Professor at ksauhs, Saudi Arabia

Dr. Israa Abdullah Malli is an accomplished academic and researcher in the field of microbiology with a focus on infectious diseases and medical education. She holds the position of Assistant Professor of Microbiology at a prominent health sciences university, where she is deeply involved in teaching, research, and mentorship. Dr. Malli’s work emphasizes the intersection of microbiology, epidemiology, and biotechnology, contributing significantly to both academic and scientific communities. She has made notable advancements in understanding microbial behavior, antibiotic resistance, and the role of probiotics in health. Additionally, her leadership roles in academic committees reflect her commitment to shaping the next generation of health professionals.

Profile Verified:

Orcid | Scopus

Education:

Dr. Malli’s educational background is rooted in prestigious institutions. She earned her Ph.D. in Microbiology from Howard University, Washington, DC, in 2017, where her research focused on the molecular mechanisms of bacterial resistance. She holds a Master’s in Biotechnology from The Catholic University of America, Washington, DC, and a Bachelor of Medical Laboratories from King Abdul-Aziz University. She also completed her Master’s in Medical Education from King Saud Bin-Abdul-Aziz University for Health Sciences in 2020, further enhancing her ability to contribute to educational advancements in medical sciences.

Experience:

With over a decade of experience, Dr. Malli has held various academic and administrative roles. She has been serving as Assistant Professor of Microbiology and Assistant Dean for Academic Affairs at King Saud Bin-Abdul-Aziz University for Health Sciences. Her responsibilities include designing and coordinating microbiology courses, delivering lectures, and providing one-on-one mentorship to students. In addition, she has served in leadership capacities such as the In-Charge of the Assessment Unit and Deputy Chair of the Department of Basic Medical Sciences, where she helped enhance the academic framework of the university. Her leadership in academic and research committees has shaped several key initiatives aimed at improving student outcomes and fostering a culture of scientific inquiry.

Research Interests:

Dr. Malli’s research interests primarily focus on the molecular biology of infectious diseases, specifically the mechanisms behind antibiotic resistance and the use of probiotics for improving patient health. Her research into the role of reactive oxygen species in bacterial disinfection processes has contributed to advancing the understanding of bacterial resistance mechanisms, particularly in foodborne pathogens like Salmonella. Dr. Malli also explores the potential of probiotics in mitigating health complications in cancer patients. Her interdisciplinary research combines microbiology, biotechnology, and medical education to address critical global health challenges, particularly those concerning antimicrobial resistance.

Awards:

Dr. Malli has received numerous accolades throughout her academic career, underscoring her contributions to research and education. Notably, she has been recognized for her mentorship, with several of her students winning prestigious awards at research forums. Her efforts in advancing medical research have been acknowledged with Certificates of Appreciation for her role in scientific committees and research forums. These honors reflect her dedication to fostering an environment of excellence and scholarly achievement within the academic community. Her leadership in educational innovation and student mentorship has also been widely recognized.

Publications:

Dr. Malli has authored several impactful research articles in peer-reviewed journals, contributing significantly to her field. Here are some of her notable publications:

  1. “Application of Eugenol to Control Salmonella in Poultry” (Veterinary Sciences, 2023) 🐔 This article explores the use of eugenol as a potential agent to control Salmonella in poultry, providing insights into natural antimicrobial interventions.
  2. “Sublethal Chlorine Concentration and Antibiotic Resistance in Salmonella” (Applied Microbiology, 2024) 🧫 In this study, Dr. Malli investigates the relationship between sublethal chlorine concentrations and the development of antibiotic resistance in Salmonella, contributing to the understanding of resistance mechanisms in food safety.
  3. “Reactive Oxygen Species Mediate the Bactericidal Activity of Chlorine Against Salmonella” (Current Microbiology, 2024) 💡 This research delves into the bactericidal properties of chlorine, showing how reactive oxygen species play a critical role in eliminating Salmonella.
  4. “Probiotic Potential of Bifidobacterium in Cancer Patients” (Acta Microbiologica Bulgarica, 2024) 🦠 Dr. Malli’s research on probiotics highlights their therapeutic potential in cancer patients, showing the significance of gut microbiota in cancer management.
  5. “From Inflammation to Cancer: Genetic Polymorphisms and Gastric Cancer” (Springer, 2021) 🧬 This work examines genetic polymorphisms and their connection to gastric cancer susceptibility, offering insights into molecular pathways involved in cancer development.
  6. “Host-Targeted Antivirals and HIV-1 Infection Mechanisms” (Preprints, 2021) 🦠 In this article, Dr. Malli discusses how host-targeted antivirals can inhibit HIV-1 infection by affecting key viral mechanisms, adding to the broader field of antiviral research.
  7. “Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma” (Journal of Global Infectious Diseases, 2024) 🦠 This publication provides a comprehensive meta-analysis of how co-infection with hepatitis B and C viruses contributes to the risk of liver cancer, influencing future clinical approaches to hepatitis treatment.

Conclusion:

Dr. Israa Abdullah Malli’s academic and research contributions are impressive and deserving of the Best Researcher Award. Her work in microbiology, specifically her research on antimicrobial resistance and probiotics, has added significant value to the scientific community. Additionally, her commitment to education and mentorship has left a lasting impact on students and fellow researchers alike. As she continues to expand her research and foster interdisciplinary collaborations, Dr. Malli is poised to contribute even more to global health challenges, particularly in the areas of infectious diseases and cancer. Her work exemplifies the power of academic rigor combined with compassionate mentorship, making her a highly deserving nominee for this prestigious award.

 

 

 

 

Monika Janeczko | Microbiology | Best Researcher Award

Dr. Monika Janeczko | Microbiology | Best Researcher Award

Habilitated doctor | The John Paul II Catholic University of Lublin |Poland

Monika Janeczko is an accomplished academic and researcher specializing in molecular biology and pharmaceutical sciences. Currently an academic teacher and scientist at the Department of Molecular Biology, John Paul II Catholic University of Lublin, she has a deep focus on microbial pathogenesis, antifungal therapies, and biotechnological applications in medicine. Her research interests lie in understanding the molecular interactions between pathogens, particularly Candida species, and the development of novel therapeutic agents, including the application of nanoparticles and plant bioactive compounds. Dr. Janeczko’s academic career has spanned several prestigious institutions, and she is an active contributor to research projects funded by the National Science Centre of Poland. Her work is marked by interdisciplinary approaches combining microbiology, biochemistry, and pharmacology to develop innovative solutions for healthcare.

Profile

Scopus

Education
Dr. Janeczko’s educational journey is grounded in rigorous academic training. She earned her PhD in Pharmaceutical Sciences from the Medical University of Lublin in 2015, followed by a Doctor Habilitatus in Medical and Health Sciences from Nicolaus Copernicus University in Toruń in 2023. Her academic background also includes postgraduate studies in philosophy at the John Paul II Catholic University of Lublin and an M.Sc. in Biochemistry from Maria Curie-Skłodowska University. Her foundation in the biological sciences was established during her secondary education at the First High School in Hrubieszów, with a focus on biology and chemistry.

Experience
With over a decade of experience in academia, Dr. Janeczko has held a faculty position at the John Paul II Catholic University of Lublin since 2007. She has taught a wide range of subjects including microbiology, molecular biology, biochemistry, and biotechnological methods in pharmacy to both undergraduate and graduate students. Her teaching responsibilities extend to other institutions, including Collegium Masoviense in Żyrardów, where she lectures on infectious diseases and microbiology. Additionally, Dr. Janeczko has participated in various high-level research internships, notably at the Department of Microbiology at Jagiellonian University’s Collegium Medicum in 2022. Throughout her career, she has been deeply involved in interdisciplinary research and the mentoring of students in laboratory settings.

Research Interests
Dr. Janeczko’s research primarily focuses on microbial pathogenesis, especially concerning Candida species, and the development of novel antifungal agents. Her current work investigates the cellular and molecular mechanisms underlying the antifungal properties of metallocarborates and bioactive plant metabolites. She is also exploring the potential of nanoparticles as tools for enhancing the biosynthesis of bioactive compounds in plant species with health benefits. Her previous work has involved studying the antifungal activity of naphthoquinones, flavonoids, and the development of new anti-cancer and anti-fungal compounds for clinical applications. Moreover, Dr. Janeczko has made significant contributions to understanding the evolutionary aspects of repetitive DNA and mobile elements in plant species, a crucial aspect of genetic diversity and adaptability.

Awards
Dr. Janeczko’s scientific contributions have earned her multiple accolades. She has received the Rector’s Award for Unique Scientific Achievements on several occasions, including in 2018, 2019, 2020, and 2024. These awards recognize her ongoing commitment to advancing the field of molecular biology and her impactful research on novel pharmaceutical compounds. These honors reflect her standing as a leading scientist in her field, contributing substantially to both theoretical knowledge and practical applications in biomedicine.

Publications
Dr. Janeczko has published several impactful papers in peer-reviewed journals, contributing significantly to the fields of microbiology, pharmacology, and molecular biology. Her most recent publications include:

  1. Janeczko, M., Skrzypek, T. (2025). Relationships Between Candida auris and the Rest of the Candida World – Analysis of Dual-Species Biofilms and Infections. Pathogens, 14(1), 40.
  2. Janeczko, M., Kochanowicz, E., Górka, K., Skrzypek, T. (2024). Quinalizarin as a potential antifungal drug for the treatment of Candida albicans fungal infection in cancer patients. Microbiology Spectrum, e0365223.
  3. Janeczko, M., Kochanowicz, E. (2024). Biochanin A Inhibits the Growth and Biofilm of Candida Species. Pharmaceuticals, 17(1):89.
  4. Kubiński, K., Górka, K., Janeczko, M., et al. (2023). Silver Is Not Equal to Silver: Synthesis and Evaluation of Silver Nanoparticles with Low Biological Activity, and Their Incorporation into C12-Alanine-Based Hydrogel. Molecules, 28(3), 1194.
  5. Kubiński, K., Masłyk, M., Janeczko, M., et al. (2022). Metallacarborane Derivatives as Innovative Anti-Candida albicans Agents. Journal of Medicinal Chemistry, 65(20), 13935–13945.
  6. Golczyk, H., Hřibová, E., Doležel, J., et al. (2022). Migration of repetitive DNAs during evolution of the permanent translocation heterozygosity in the oyster plant (Tradescantia section Rhoeo). Chromosoma, 10.1007/s00412-022-00776-1.
  7. Janeczko, M., Gmur, D., Kochanowicz, E., et al. (2022). Inhibitory effect of a combination of baicalein and quercetin flavonoids against Candida albicans strains isolated from the female reproductive system. Fungal Biology, 126(6-7), 407–420.

Her research articles have been cited in numerous studies, contributing to the academic community’s understanding of antifungal therapy and the molecular biology of pathogenic microorganisms.

Conclusion
Dr. Monika Janeczko’s work exemplifies the intersection of academic rigor and practical application in biotechnology and pharmaceutical sciences. With a solid foundation in molecular biology, her research has paved the way for novel therapeutic strategies, particularly in the fight against fungal infections. Her dedication to research and teaching, combined with her continuous contributions to science, make her a valuable asset to both the academic community and the broader scientific world. Through her ongoing research projects, she continues to push the boundaries of knowledge in her field, with the potential to significantly impact global health initiatives.